INTERCHEM (Ireland) Ltd. is delighted to launch a new, COX-2 selective NSAID tablet with 24-hour efficacy for horses

Interchem (Ireland) Ltd. based in Tallaght, Dublin, supply veterinary practices throughout Ireland with equine speciality products including Audevard complementary nutrition and Precision Microbes. They are delighted to add the latest generation cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug (NSAID) to its equine range.

Clinical efficacy:

The unique tablet formulation has proven clinical efficiency on pain associated with osteoarthritis. The anti-inflammatory properties of the tablet have been shown to have strong analgesic response in horses with osteoarthritis demonstrated by improvement in lameness scores. Studies have shown equally strong clinical efficacy to alternative medicines on the market.

Duration of action:

The product has a long duration of action with sustained therapeutic effect over 24 hours. By maintaining high blood concentrations following tablet administration, a gap in pain management is prevented. Therapeutic gap is commonly present with other NSAIDs that do not deliver sustained levels following administration. This means horses are not left without pain relief and waiting for the next dose.

Low risk of side effects:

A concentrated action on COX-2 allows this product to act specifically on pain and inflammation while preserving the physiological action of COX-1 and minimising side effects associated with COX-1 inhibition. Nonselective COX inhibitors may result in adverse effects such as gastric ulceration.

Talk to your local veterinarian to find out more about Interchem’s range of equine products.